Viemed Healthcare Stock Performance
| VMD Stock | USD 7.83 0.16 2.00% |
The entity has a beta of 0.56, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Viemed Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Viemed Healthcare is expected to be smaller as well. At this point, Viemed Healthcare has a negative expected return of -0.14%. Please make sure to validate Viemed Healthcare's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Viemed Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Viemed Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (2.00) | Five Day Return (2.25) | Year To Date Return (3.69) | Ten Year Return 336.55 | All Time Return 336.55 |
1 | Disposition of 15000 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3 | 11/19/2024 |
2 | Viemed Healthcare director sells shares worth 255,900 | 11/21/2024 |
3 | Disposition of 24005 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3 | 11/25/2024 |
4 | Ingles Markets, Tesla And Other Big Stocks Moving Lower In Fridays Pre-Market Session | 12/27/2024 |
5 | Disposition of 1927 shares by Trae Fitzgerald of Viemed Healthcare at 7.62 subject to Rule 16b-3 | 01/02/2025 |
6 | Disposition of 10719 shares by Heltz Sabrina of Viemed Healthcare subject to Rule 16b-3 | 01/15/2025 |
7 | Disposition of 2131 shares by Cambre Jerome of Viemed Healthcare subject to Rule 16b-3 | 01/17/2025 |
8 | Acquisition by Cambre Jerome of 8789 shares of Viemed Healthcare subject to Rule 16b-3 | 01/21/2025 |
9 | Acquisition by William Zehnder of 25661 shares of Viemed Healthcare subject to Rule 16b-3 | 01/22/2025 |
10 | Acquisition by Moore Michael of 18979 shares of Viemed Healthcare subject to Rule 16b-3 | 01/23/2025 |
11 | Disposition of 8948 shares by Moore Michael of Viemed Healthcare subject to Rule 16b-3 | 01/29/2025 |
12 | Acquisition by Cambre Jerome of 8619 shares of Viemed Healthcare subject to Rule 16b-3 | 01/31/2025 |
13 | Acquisition by Casey Hoyt of 40068 shares of Viemed Healthcare subject to Rule 16b-3 | 02/07/2025 |
14 | Acquisition by William Zehnder of 269 shares of Viemed Healthcare subject to Rule 16b-3 | 02/14/2025 |
| Begin Period Cash Flow | 16.9 M |
Viemed |
Viemed Healthcare Relative Risk vs. Return Landscape
If you would invest 861.00 in Viemed Healthcare on November 19, 2024 and sell it today you would lose (78.00) from holding Viemed Healthcare or give up 9.06% of portfolio value over 90 days. Viemed Healthcare is generating negative expected returns assuming volatility of 1.7096% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Viemed, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Viemed Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viemed Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Viemed Healthcare, and traders can use it to determine the average amount a Viemed Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0826
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VMD |
Estimated Market Risk
| 1.71 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viemed Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viemed Healthcare by adding Viemed Healthcare to a well-diversified portfolio.
Viemed Healthcare Fundamentals Growth
Viemed Stock prices reflect investors' perceptions of the future prospects and financial health of Viemed Healthcare, and Viemed Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viemed Stock performance.
| Return On Equity | 0.0888 | ||||
| Return On Asset | 0.0686 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 300.78 M | ||||
| Shares Outstanding | 38.94 M | ||||
| Price To Earning | 29.88 X | ||||
| Price To Book | 2.44 X | ||||
| Price To Sales | 1.42 X | ||||
| Revenue | 183.01 M | ||||
| Gross Profit | 129.18 M | ||||
| EBITDA | 36.71 M | ||||
| Net Income | 10.24 M | ||||
| Cash And Equivalents | 21.92 M | ||||
| Cash Per Share | 0.57 X | ||||
| Total Debt | 10.32 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.34 X | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | 45.21 M | ||||
| Earnings Per Share | 0.25 X | ||||
| Market Capitalization | 304.87 M | ||||
| Total Asset | 154.9 M | ||||
| Retained Earnings | 79.5 M | ||||
| Working Capital | 6.24 M | ||||
About Viemed Healthcare Performance
By analyzing Viemed Healthcare's fundamental ratios, stakeholders can gain valuable insights into Viemed Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Viemed Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Viemed Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.66 | 45.17 | |
| Return On Tangible Assets | 0.09 | 0.09 | |
| Return On Capital Employed | 0.12 | 0.13 | |
| Return On Assets | 0.08 | 0.07 | |
| Return On Equity | 0.10 | 0.10 |
Things to note about Viemed Healthcare performance evaluation
Checking the ongoing alerts about Viemed Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Viemed Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viemed Healthcare generated a negative expected return over the last 90 days | |
| Viemed Healthcare has a strong financial position based on the latest SEC filings | |
| About 69.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by William Zehnder of 269 shares of Viemed Healthcare subject to Rule 16b-3 |
- Analyzing Viemed Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viemed Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Viemed Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viemed Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viemed Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viemed Healthcare's stock. These opinions can provide insight into Viemed Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Viemed Stock analysis
When running Viemed Healthcare's price analysis, check to measure Viemed Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viemed Healthcare is operating at the current time. Most of Viemed Healthcare's value examination focuses on studying past and present price action to predict the probability of Viemed Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viemed Healthcare's price. Additionally, you may evaluate how the addition of Viemed Healthcare to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |